eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse eHealthMe       Feature support groups

From FDA reports: drug interactions between Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon for a Male patient aged 61

This is a personalized study for a 61 year old male patient. The study is created by eHealthMe based on reports of 2 people who take the same drugs and have drug interactionsfrom FDA.

On Aug, 17, 2014: 2 people who reported to have interactions when taking Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon are studied

Trend of Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon's drug interactions, side effects, and effectiveness reports (4929019)

Information of the patient in this study:

Age: 61

Gender: male

Drugs taking:
- Dalteparin Sodium
- Ibuprofen Tablets: used for 1 - 6 months
- Codeine Linctus
- Dalteparin Sodium: used for < 1 month
- Dalteparin Sodium: used for < 1 month
- Omeprazole: used for 1 - 6 months
- Prednisolone: used for 1 - 6 months
- Erythromycin
- Gaviscon

Drug interactions have: Disease Progression, Lung Cancer Metastatic, Pulmonary Haemorrhage

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 61 (±5):

InteractionNumber of reports
Disease Progression2 (100.00%)
Lung Cancer Metastatic (lung cancer spreads to other parts)2 (100.00%)
Pulmonary Haemorrhage (acute bleeding from the lung)2 (100.00%)

Most common interactions experienced by males aged 61 (±5) in the use of Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon:

InteractionNumber of reports
Disease Progression2
Lung Cancer Metastatic (lung cancer spreads to other parts)2
Pulmonary Haemorrhage (acute bleeding from the lung)2

Most common interactions experienced by males aged 61 (±5) in long term use of Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Disease Progression2 (100.00%)
Lung Cancer Metastatic (lung cancer spreads to other parts)2 (100.00%)
Pulmonary Haemorrhage (acute bleeding from the lung)2 (100.00%)

Most common interactions experienced by people in the use of Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon:

InteractionNumber of reports
Disease Progression2
Lung Cancer Metastatic (lung cancer spreads to other parts)2
Pulmonary Haemorrhage (acute bleeding from the lung)2

Most common interactions experienced by people in long term use of Dalteparin Sodium, Ibuprofen Tablets, Codeine Linctus, Omeprazole, Prednisolone, Erythromycin, Gaviscon:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.